Take the chance to win 2-night stay in Dubai for two people! Not only will you enjoy an incredible vacation
Written by David and verified by Ionis Following Ionis’ recent announcement about the upcoming clinical trial, we aim to provide
Charlie is one the children participating in the natural history study (NHS) conducted by Ionis Pharmaceuticals in the US. The
In February 2024, David Covini, President of DupMECP2, visited the innovative biotech company HuidaGene Therapeutics in Shanghai. The visit provided
A Revolutionary Technology and its Potential in MECP2 Duplication Syndrome The world of genetic engineering has been revolutionized by the
Huidagene Therapeutics is a biotechnology company based in Shanghai and New Jersey, focusing on discovering, engineering, and developing novel CRISPR-based
The world of healthcare can often seem complex, especially when it comes to understanding the various systems and studies that
On November 25, 2023, our charity concert with the band “Live & Pur” was held, welcoming over 200 guests, including
On the 28th of October, members of our team: Ana (board member), Caroline (board member, vice president) and Dr. Gudrun
Exactly a year ago, the “Lasst uns MDS heilen – DupMECP2” association came to life. The association’s story began with
